INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
SB

Stone Benjamin

Chief Business OfficerCIK 0002128786

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score21
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SB
Stone BenjaminChief Business Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
42.5K sh
Nov 1, 2026Nov 3, 2026
traded Nov 1, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    First Tracks Biotherapeutics, Inc.Chief Business Officer · May 14, 2026
21
SB
Stone BenjaminChief Business Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A
—
60.5K sh
Aug 15, 2026
Aug 18, 2026
traded Aug 15, 2026
+3d
SEC FORM 4

Evidence

9
SB
Stone BenjaminChief Business Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
26.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

9
SB
Stone BenjaminChief Business Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
72.3K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence